Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Expenses (2016 - 2025)

STRATA Skin Sciences' Operating Expenses history spans 14 years, with the latest figure at $5.1 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 48.98% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.6 million, a 20.7% decrease, with the full-year FY2025 number at $22.6 million, down 20.7% from a year prior.
  • Operating Expenses hit $5.1 million in Q4 2025 for STRATA Skin Sciences, down from $5.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for SSKN hit a ceiling of $10.0 million in Q4 2024 and a floor of $5.1 million in Q4 2025.
  • Historically, Operating Expenses has averaged $6.4 million across 5 years, with a median of $6.4 million in 2022.
  • Biggest five-year swings in Operating Expenses: surged 58.82% in 2021 and later plummeted 48.98% in 2025.
  • Tracing SSKN's Operating Expenses over 5 years: stood at $6.6 million in 2021, then rose by 1.39% to $6.7 million in 2022, then grew by 22.76% to $8.2 million in 2023, then grew by 21.91% to $10.0 million in 2024, then plummeted by 48.98% to $5.1 million in 2025.
  • Business Quant data shows Operating Expenses for SSKN at $5.1 million in Q4 2025, $5.4 million in Q3 2025, and $6.6 million in Q2 2025.